Investor Relations
At the intersection of regenerative medicine and hospitality, BioLife Science is building a scalable platform for personalized health and longevity.
Contact Investor RelationsInvestor Thesis
The global regenerative medicine category is expanding rapidly, supported by advances in stem cells, peptides, AI-driven personalization, and consumer demand for proactive longevity care. BioLife Science is positioned to disrupt legacy wellness models with a high-touch, data-driven, membership experience that scales.
- Market Tailwinds: Rising adoption of precision health, hormone optimization, and recovery therapies.
- Disruption: Science-first protocols delivered in elevated, spa-inspired centers.
- Scalability: Standardized clinical playbooks, membership systems, and franchise-ready operations.
- Resilience: Diversified recurring revenue and membership economics.
Governance & Board
BioLife Science operates with transparent, disciplined governance — aligning clinical integrity with sustainable growth.
- Board of Directors: Leaders across regenerative medicine, healthcare, and franchising.
- Medical Advisory Council: Clinicians overseeing protocol safety and compliance.
- Corporate Governance: Ethical standards, risk management, and accountability.
Expansion Roadmap
Franchise Rollout Begins
BioLife Science transitions from development to franchise activation, launching its first territories through the Founding Franchisee Program. This milestone demonstrates franchise demand, market validation, and early system adoption.
Corporate Growth & Validation
Fifteen corporate-owned flagship centers across Texas become the operational blueprint, refining systems, staffing, and guest experience metrics for scalable replication.
Hybrid Growth Model
Expansion accelerates through corporate flagships, physician-franchise partners, and select international joint ventures — positioning BioLife as a global wellness brand.
BioLife’s strategy balances medical integrity with scalable growth.
Investor FAQ
What is BioLife Science?
BioLife Science is a next-generation regenerative wellness brand merging advanced biologic therapies with luxury guest experiences.
How is BioLife structured for growth?
BioLife operates a hybrid model of corporate-owned and physician-owned centers for scalability and shared standards.
What differentiates BioLife from other brands?
Each center is designed as a first-class wellness destination, combining medical precision and recurring membership revenue.
Who leads BioLife Science?
Founded by Bill Jones with a leadership team of medical, hospitality, and franchise experts.
Can I access detailed investor information?
Accredited investors may request access to detailed data via the Investor Inquiry form.
Partner in the Future of Regenerative Wellness
BioLife Science represents a rare opportunity to participate in precision-based, physician-driven wellness. Our platform is built for scalability, brand value, and long-term alignment.
Forward-Looking Statements
This page includes forward-looking statements regarding BioLife Science’s growth, market opportunities, and business strategy. These statements are based on current expectations and are subject to risks and uncertainties that may cause actual results to differ materially. Nothing on this page constitutes an offer to sell or a solicitation to buy securities.
Franchise Territories
Available now: Texas, Louisiana, Mississippi, Oklahoma, Florida, Alabama, Georgia. All other states: franchise territories coming soon.
United States Coverage
Texas Detail
Planned locations shown below — Coming Summer 2026
